| PI Name & Department/Division |
|
Project Title |
|
|
|
Ravi Bhatia, MD
Hematopoietic Stem Cell & Leukemia |
|
Gene expression abnormalities in hematopoietic cells from lymphoma patients at risk for t-MDS (Renewal Application) |
|
|
|
|
|
|
Smita Bhatia, MD
Population Sciences |
|
Constitutional short telomeres as genetic susceptibility markers for adverse events in patients undergoing autologous HCT for lymphoma (Renewal Application) |
|
|
|
David Horne, PhD
Sangkil Nam, PhD
Molecular Medicine |
|
Development of a First-In-Class dual EGFR/Microtubule Small Molecule Inhibitor for the Treatment of Lymphoma
|
|
|
|
|
|
|
Wendong Huang, PhD
Gene Regulation & Drug Discovery |
|
Targeting lymphoma by a natural compound
|
|
|
|
|
|
|
Markus Kalkum, PhD
Immunology
|
|
An antifungal Vaccine to Improve the Survival of Patients Treated for Lymphomas and other Hematologic Malignancies |
|
|
|
|
|
|
Amrita Krishnan, MD
John Zaia, MD
Hem/HCT |
|
Molecular, Immunologic and Viral analyses of AIDS related non Hodgkin Lymphoma
|
|
|
|
|
|
|
Takahiro Maeda, PhD
Hematopoietic Stem Cell & Leukemia |
|
Signature-based small molecule screening for Non-Hodgkin Lymphoma (Renewal Application)
|
|
|
|
|
|
|
Sophia Wang, PhD
Leslie Bernstein, PhD
Larry Weiss, MD
Etiology |
|
Molecular and genetic determinants of NHL survival (Renewal Application)
|
|
|
|
|
|
|
Sophia Wang, PhD
Leslie Bernstein, MD
James Lacey
Stephen J. Forman, MD
Rebecca Nelson
Etiology |
|
Etiologic role of implants in T-cell Lymphomas (Renewal Application)
|
|
|
|
|
|
|
John Zaia, MD
Auayporn Nademanee, MD
Amrita Krishnan, MD
Virology |
|
Co-stimulatory molecule profile in B-cell Lymphoma subjects undergoing auto and allo-HCT (Renewal Application) |
|
|
|
|
|
|
Chih-Pin Liu, PhD
Immunology |
|
Molecular regulation of T lymphoma cell death (Renewal Application) |
|
|
|
|
|
|
Yuan Chen, PhD
Molecular Medicine |
|
Metabolomic biomarkers associated with the Development of T-MDS |
|
|
|
|
|
|
Yun Yen, MD
Lufen Chang, PhD
Clinical & Molecular Pharmacology |
|
Targeting TNFa/IKKb/NF-kB canonical pathway for the treatment of MCL
|
|
|
|
Garrett Larson, PhD
Ryotaro Nakamura, MD
Molecular Medicine |
|
Influence of genomic structural variants on GVHD and Relapse Risk in Lymphoma Patients Treated with Allogeneic HSCT (Renewal Application) |
|
|
|
|
|
|
Robert Chen, MD
Hem/HCT |
|
Developing an in vivo model of siRNA therapy in mantle cell lymphoma |
|
|
|
Xiuli Wang, PhD
Hem/HCT |
|
Platform development for deriving CD19 specific central memory T cells for clinical trials (Renewal Application) |
|
|
|
|
|
|
Defu Zeng, MD
Diabetes, Endocrinology & Metabolism |
|
Separation of graft versus lymphoma from graft versus host disease via anti-CD3-based conditioning (Renewal Application) |
|
|
|
|
|
|
David Ann, PhD
Mei Kong, PhD
Molecular Pharmacology |
|
Targeting metaboloc pathways for B lymphoma therapy |
|
|
|
|
|
|
Batia Avni, MD
Cancer Immunotherapeutics & Tumor Immunology |
|
Combination of anti-CD-20-IL2 Immunocytokine and Lenalidomide for the enhancement of NK Cells in Human Lymphoma Bearing SCID Xenograft Model |
|
|
|
|
|
|
Batia Avni, MD
Cancer Immunotherapeutics & Tumor Immunology |
|
Defining the presence and content of tumor derived exosomes in the peripheral circulation of patients with b cell non Hodgkin lymphomas |
|
|
|
|
|
|
David Colcher, PhD
Cancer Immunotherapeutics & Tumor Immunology |
|
Preparation of an anti-CD25 antibody Conjugate for Phase I/II Studies of Autologous Hematopoietic Cell Transplant in Conjuction with BEAM Conditioning for Patients with CD25+ Hodgkin or T-cell non-Hodgkin Lymphomas |
|
|
|
Don Diamond, PhD
Virology |
|
Optimizing shRNA Approaches for control of Experimental Murine Lymphoma using Salmonella Delivery Systems |
|
|
|
Maciej Kujawski, PhD
Christine Brown, PhD
Cancer Immunotherapeutics & Tumor Immunology
|
|
Blocking Stat3 signaling in lymphoma-specific CD8+ T cells to improve their anti-tumor responses
|
|
|
|
Wendy Landier, PhD, RN
Smita Bhatia, MD
Population Sciences |
|
Quadrivalent Human Papillomavirus (HPV) Vaccine in Lymphoma Survivors |
|
|
|
Heehyoung Lee, PhD
Cancer Immunotherapeutics & Tumor Immunology |
|
Targeting S1P/S1PR1-STAT3 signaling pathway: novel therapeutic strategy for diffuse large B cell lymphoma |
|
|
|
Ren-Jang Lin, PhD
Molecular & Cellular Biology |
|
Post-transcriptional deregulation of oncogenic microRNAs in lymphoma |
|
|
|
V.N. Ngo, PhD
Hematopoietic Stem Cell & Leukemia |
|
Functional Genetic Screen for Novel Molecular Targets in Mantle Cell Lymphoma |
|
|
|
Tim O'Connor, PhD
Res-Biology |
|
Exploiting DNA Repair Defects in Hodgkin Lymphoma |
|
|
|
Can-Lan Sun, PhD
Population Sciences
|
|
Urinary Tea Polyphenols an dLymphoma: the Singapore Chinese Health Study and Shanghai Cohort Study |
|
|
|
|
|
|
Zuoming Sun, PhD
Immunology |
|
Interplay between inflammation and glycolysis in lymphoma |
|
|
|
|
|
|
John Williams, PhD
Molecular Medicine |
|
Tumor activated Procalins: CTLA-4 antagonists to treat lymphoma |
|
|
|
John Williams, PhD
David Colcher, PhD
Andrew Raubitschek, MD
Molecular Medicine |
|
Development of a synergistic anti-CD20 mAb / holetope-Fc combination for enhanced treatment of lymphoma |
|
|
|
|
|
|
Defu Zeng, PhD
Diabetes, Endocrinology & Metabolism |
|
BAFF-R Aptamer-SiRNA Chimeras for prevention and Treatment of Chronic GVHD and Lymphoma Relapse in HCT Recipients |
